Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes.
Thermo Fisher Scientific and Charles River Laboratories have joined a consortium aiming to develop a robotic manufacturing system capable of creating gene modified cell therapies on an industrial scale. Both companies say the initiative will result in ‘industry-defining technology’ that will lower manufacturing costs, reduce bottlenecks and increase patient access to cell and gene therapies.
The Consortium was established by Multiply Labs, a US-based robotics developer, in 2021 and the team is rounded out by UCSF and Cytiva. Robotics development activities are coordinated by Multiply Labs, while the cell manufacturing process is overseen by UCSF through a sponsored research agreement.
Speaking about the news, Multiply Labs CEO Fred Parietti said: ‘We are very excited to combine Multiply Labs’ cutting-edge expertise in cloud-controlled robotics with the GMP-ready, market-leading instrumentation technologies by Cytiva, Thermo Fisher and Charles River’.
Thermo Fisher will collaborate with Multiply Labs on automating the operation of incubators that are utilized in the expansion of cells to therapeutically relevant levels, while Charles River will integrate its microbial testing equipment into the Multiply Labs Cluster to enable in-process product release testing. Cytiva, an early member, focuses on the automation of the Xuri bioreactor.
Image: The Multiply Labs Cluster, a configuration of 2x5 cube modules on each side that stands nine feet tall.
Speaking to CPHI, Matthew Hewitt, Executive Director, Scientific Services Cell and Gene Therapy at Charles River, explained that while cell and gene therapies have the potential to offer curative therapeutics, the complexity of manufacturing them presents a major hurdle to patient access.
‘To fully realise the promise of cell and gene therapies, therapeutic developers need access to closed, automated manufacturing platforms which efficiently scale manufacturing for large patient populations,’ he said.
Betty Woo, Vice President and General Manager of Cell and Gene Therapy at Thermo Fisher Scientific, echoed these sentiments.
She said: ‘Automating the manufacturing process removes limiting factors such as the manual processing of cells, which may be susceptible to human error, while increasing the robustness and reproducibility of the manufacturing process. In short, automation is necessary for industrializing cell therapy manufacturing.'
Woo added that the automated process maintains aseptic conditions, which is critical for patient safety, and increases product quality through process reproducibility, robustness, and consistency.
‘By increasing the reproducibility of this process, we can better plan production to meet the demand for these life-saving therapies,’ she said.
According to a recent Catalent report, bottlenecks are the most common hurdles faced by cell and gene therapy developers. Geopolitical concerns and issues arising from the COVID-19 pandemic have exacerbated pre-existing difficulties in this area.
As therapies for indications with large patient populations (such as solid tumors) develop, the ability to scale manufacturing efficiently will become even more important.
The Consortium plans to present this technology at UCSF by the end of this year.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance